#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2354285	Functional	PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory)		635	ALA1201862	biochemical format	PubChem BioAssays
2.	ALA3215214	Functional	PubChem BioAssay. Effect of RAD 52 Inhibitors on Growth of CAPAN-1 Cells Measured in Cell-Based System Using Imaging - 7018-03_Inhibitor_Dose_DryPowder_Activity_Set3. (Class of assay: confirmatory)		34	ALA1201862	cell-based format	PubChem BioAssays
3.	ALA3214880	Functional	PubChem BioAssay. Effect of RAD 52 Inhibitors on Growth of CAPAN-1 Cells Measured in Cell-Based System Using Imaging - 7018-03_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory)		28	ALA1201862	cell-based format	PubChem BioAssays
4.	ALA4417894	Binding	Inhibition of RAD52 (unknown origin) assessed as effect on ssDNA annealing using ssDNA oligonucleotide by fluorescence-quenching assay	Homo sapiens	17	ALA4417629	single protein format	Patent Bioactivity Data
5.	ALA4417895	Binding	Inhibition of RAD52 (unknown origin) assessed as inhibition of DNA pairing using [32P]-ssDNA by measuring D-loop formation incubated for 15 mins by gel electrophoresis method	Homo sapiens	17	ALA4417629	single protein format	Patent Bioactivity Data
6.	ALA4417899	Binding	Binding affinity to RAD52 (unknown origin) by SPR assay	Homo sapiens	2	ALA4417629	single protein format	Patent Bioactivity Data
7.	ALA4417900	Binding	Inhibition of RAD52 (unknown origin) expressed in BCR-ABL1-positive and BRCA1-deficient mouse 32Dcl3 cells expressing GFP-RAD52 assessed as reduction in cisplatin-induced RAD52 foci formation at 2.5 uM by AlexaFluor-594 staining based inverted fluorescence microscopy relative to control	Homo sapiens	2	ALA4417629	cell-based format	Patent Bioactivity Data
8.	ALA4417901	Binding	Inhibition of RAD52 (unknown origin) expressed in BCR-ABL1-positive and BRCA1-deficient mouse 32Dcl3 cells expressing GFP-RAD52 assessed as cisplatin-induced RAD52 foci formation at 2.5 uM by AlexaFluor-594 staining based inverted fluorescence microscopy (Rvb = 38.7 +/- 10%)	Homo sapiens	2	ALA4417629	cell-based format	Patent Bioactivity Data
9.	ALA4417902	Binding	Inhibition of RAD52 (unknown origin) expressed in BCR-ABL1-positive and BRCA1-deficient mouse 32Dcl3 cells expressing GFP-RAD52 assessed as cisplatin-induced RAD52 foci formation by measuring fraction of cell without foci at 2.5 uM by AlexaFluor-594 staining based inverted fluorescence microscopy (Rvb = 48.4 +/- 6.2%)	Homo sapiens	2	ALA4417629	cell-based format	Patent Bioactivity Data
10.	ALA4417905	ADME	Effect on RAD52 (unknown origin) expressed in BCR-ABL1-positive and BRCA1-deficient mouse 32Dcl3 cells expressing GFP-RAD52 assessed as induction of RAD52 foci formation by AlexaFluor-594 staining based inverted fluorescence microscopy	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
11.	ALA4417906	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SA-GFP assessed as reduction in single strand DNA annealing incubated for 48 hrs by GFP+ positive cells detection based flow cytometry	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
12.	ALA4417907	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SA-GFP assessed as reduction in single strand DNA annealing at 30 uM incubated for 48 hrs by GFP+ positive cells detection based flow cytometry relative to control	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
13.	ALA4417911	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SSA-GFP assessed as inhibition of repair of I-Scel-induced double stranded breaks by measuring green fluorescence at 5 uM by flow cytometry (Rvb = 7.1%)	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
14.	ALA4417912	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SSA-GFP assessed as inhibition of repair of I-Scel-induced double stranded breaks by measuring green fluorescence at 10 uM by flow cytometry (Rvb = 7.1%)	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
15.	ALA4417913	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SSA-GFP assessed as inhibition of repair of I-Scel-induced double stranded breaks by measuring green fluorescence at 15 uM by flow cytometry (Rvb = 7.1%)	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
16.	ALA4417914	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SSA-GFP assessed as inhibition of repair of I-Scel-induced double stranded breaks by measuring green fluorescence at 20 uM by flow cytometry (Rvb = 7.1%)	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
17.	ALA4417915	Binding	Inhibition of RAD52 in human U2OS cells co-expressing SSA-GFP assessed as inhibition of repair of I-Scel-induced double stranded breaks by measuring green fluorescence at 30 uM by flow cytometry (Rvb = 7.1%)	Homo sapiens	1	ALA4417629	cell-based format	Patent Bioactivity Data
18.	ALA4482620	Binding	Inhibition of RAD52 in hTERT-immortalized wild-type human GM01604 fibroblasts with BRCA2 knockdown assessed as potentiation of HU and UCN01-induced cell death by Live/Dead assay	Homo sapiens	1	ALA4482312	single protein format	Patent Bioactivity Data
19.	ALA4482621	Binding	Inhibition of RAD52 (unknown origin) assessed as reduction in RAD52-ssDNA interaction using Cy3-dT30-Cy5 ssDNA by FRET assay	Homo sapiens	26	ALA4482312	single protein format	Patent Bioactivity Data
20.	ALA4482622	Binding	Inhibition of RAD52 (unknown origin) assessed as reduction in RAD52-ssDNA interaction using Cy3-dT30-Cy5 ssDNA in presence of replication protein A by FRET assay	Homo sapiens	3	ALA4482312	single protein format	Patent Bioactivity Data